CHINA PHARMA HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $1.40 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-14.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2013-03-14
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2012 was $1.40M, a 75.34% decline from fiscal 2011.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2011 was $5.68M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|
| 2012-12-31 | $1.40M 10-K · filed 2013-03-14 |
| 2011-12-31 | $5.68M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |